These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38759794)

  • 1. Pen needle use patterns in an insured population with diabetes: U.S. retrospective claims analysis.
    Lupton L; Sun X; Javadi P; Goldman JD; Cornell S; Fernandes J; Kishorekumar S; Thach A; Sieradzan R
    J Am Pharm Assoc (2003); 2024; 64(4):102124. PubMed ID: 38759794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin pen needles: effects of extra-thin wall needle technology on preference, confidence, and other patient ratings.
    Aronson R; Gibney MA; Oza K; Bérubé J; Kassler-Taub K; Hirsch L
    Clin Ther; 2013 Jul; 35(7):923-933.e4. PubMed ID: 23790553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between insurance coverage for insulin pen needles and healthcare resource utilization among insulin-dependent patients with diabetes in China.
    Ji L; Chandran A; Inocencio TJ; Sun Z; Li Q; Qin G; Wei Z; DiMario S; Chapman RH
    BMC Health Serv Res; 2018 Apr; 18(1):300. PubMed ID: 29699587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative glycemic control, safety and patient ratings for a new 4 mm x 32G insulin pen needle in adults with diabetes.
    Hirsch LJ; Gibney MA; Albanese J; Qu S; Kassler-Taub K; Klaff LJ; Bailey TS
    Curr Med Res Opin; 2010 Jun; 26(6):1531-41. PubMed ID: 20429832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipohypertrophy Monitoring Study (LIMO): Effect of single use of 4 mm pen needles combined with education on injection site rotation on glycaemic control: Confirmation of an unpleasant truth.
    Bochanen N; Decochez K; Heleu E; Cuypers J; Vercammen C; Coremans P; Vanhaverbeke G; Shadid S; Keymeulen B; Bolsens N; De Block C
    Diabet Med; 2022 Jan; 39(1):e14672. PubMed ID: 34407260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. User experiences with second-generation 32-gauge × 4 mm vs. thinner comparator pen needles: prospective randomized trial.
    Gibney MA; Fitz-Patrick D; Klonoff DC; Whooley S; Lu B; Yue W; Glezer S
    Curr Med Res Opin; 2020 Oct; 36(10):1591-1600. PubMed ID: 32723109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a modified needle tip geometry on penetration force as well as acceptability, preference, and perceived pain in subjects with diabetes.
    Hirsch L; Gibney M; Berube J; Manocchio J
    J Diabetes Sci Technol; 2012 Mar; 6(2):328-35. PubMed ID: 22538142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost of self-monitoring of blood glucose in the United States among patients on an insulin regimen for diabetes.
    Yeaw J; Lee WC; Aagren M; Christensen T
    J Manag Care Pharm; 2012; 18(1):21-32. PubMed ID: 22235952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics Relating to Adherence and Persistence to Basal Insulin Regimens Among Elderly Insulin-Naïve Patients with Type 2 Diabetes: Pre-Filled Pens versus Vials/Syringes.
    Slabaugh SL; Bouchard JR; Li Y; Baltz JC; Meah YA; Moretz DC
    Adv Ther; 2015 Dec; 32(12):1206-21. PubMed ID: 26563324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of usability and patient preference for insulin pen needles produced with different production techniques: "thin-wall" needles compared to "regular-wall" needles: an open-label study.
    Siegmund T; Blankenfeld H; Schumm-Draeger PM
    Diabetes Technol Ther; 2009 Aug; 11(8):523-8. PubMed ID: 19698066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benchmarking Insulin Treatment Persistence Among Patients with Type 2 Diabetes Across Different U.S. Payer Segments.
    Wei W; Jiang J; Lou Y; Ganguli S; Matusik MS
    J Manag Care Spec Pharm; 2017 Mar; 23(3):278-290. PubMed ID: 28230445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence with Basal-Bolus Insulin Therapy in Patients with Type 2 Diabetes Mellitus and Effect on Clinical and Economic Outcomes: A Retrospective Claims Database Study.
    Edelman SV; Ermakova A; Xiong Y; Sieradzan R; Taylor SD
    J Manag Care Spec Pharm; 2019 Dec; 25(12):1420-1431. PubMed ID: 31550190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of a new 32-gauge × 4-mm pen needle and a 32-gauge × 6-mm pen needle on glycemic control, safety, and patient ratings in Japanese adults with diabetes.
    Miwa T; Itoh R; Kobayashi T; Tanabe T; Shikuma J; Takahashi T; Odawara M
    Diabetes Technol Ther; 2012 Dec; 14(12):1084-90. PubMed ID: 23030357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basal insulin persistence, associated factors, and outcomes after treatment initiation among people with type 2 diabetes mellitus in the US.
    Perez-Nieves M; Kabul S; Desai U; Ivanova JI; Kirson NY; Cummings AK; Birnbaum HG; Duan R; Cao D; Hadjiyianni I
    Curr Med Res Opin; 2016; 32(4):669-80. PubMed ID: 26703951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of insulin therapy delivered via a 4mm pen needle in obese patients with diabetes.
    Bergenstal RM; Strock ES; Peremislov D; Gibney MA; Parvu V; Hirsch LJ
    Mayo Clin Proc; 2015 Mar; 90(3):329-38. PubMed ID: 25662503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of V-Go Versus Multiple Daily Injections on Glycemic Control, Insulin Use, and Diabetes Medication Costs Among Individuals with Type 2 Diabetes Mellitus.
    Raval AD; Nguyen MH; Zhou S; Grabner M; Barron J; Quimbo R
    J Manag Care Spec Pharm; 2019 Oct; 25(10):1111-1123. PubMed ID: 31556817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of the reuse of needles for subcutaneous insulin injection: A systematic review and meta-analysis.
    Zabaleta-Del-Olmo E; Vlacho B; Jodar-Fernández L; Urpí-Fernández AM; Lumillo-Gutiérrez I; Agudo-Ugena J; Morros-Pedrós R; Violán C
    Int J Nurs Stud; 2016 Aug; 60():121-32. PubMed ID: 27297374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of insulin diluent leakage postinjection using two different needle lengths and injection volumes in obese patients with type 1 or type 2 diabetes mellitus.
    Ignaut DA; Fu H
    J Diabetes Sci Technol; 2012 Mar; 6(2):389-93. PubMed ID: 22538152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data.
    Lee WC; Balu S; Cobden D; Joshi AV; Pashos CL
    Clin Ther; 2006 Oct; 28(10):1712-25; discussion 1710-1. PubMed ID: 17157128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of insulin injection needles on patients' perceptions of pain, handling, and acceptability: a randomized, open-label, crossover study in subjects with diabetes.
    McKay M; Compion G; Lytzen L
    Diabetes Technol Ther; 2009 Mar; 11(3):195-201. PubMed ID: 19267582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.